Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Esophageal squamous cell carcinoma (ESCC) prognosis remains poor, and traditional models often fail to capture complex nonlinear interactions between clinical and molecular features. We integrated transcriptomic data from public datasets and an independent clinical cohort to identify prognostic biomarkers. Using weighted gene co-expression network analysis (WGCNA) and Lasso-Cox regression, we iden...
Early screening is essential for reducing the incidence and mortality of cervical cancer, and artificial intelligence-based analysis of whole slide images (WSIs) enables large-scale automated screening. However, existing methods often ignore image quality variations and inter-individual morphological differences, which limits their robustness in clinical settings. This study proposes a quality-awa...
The most common cancers in women, ovarian, cervical and endometrial, are still a significant cause of cancer-related illness and death around the worl...
Although pediatric thyroid cancer is rare, it has characteristics distinct from those of adult thyroid cancer. Thyroid nodules in children present a h...
BACKGROUND. Research on artificial intelligence (AI)-based computer-assisted detection and diagnosis (CADe/CADx) algorithms has focused primarily on d...
BACKGROUND: Ulcerative colitis (UC) exhibits a heterogeneous clinical course, complicating prognostication and therapeutic decision making. Current to...
A new AI model that predicts how noncoding DNA mutations alter gene regulation is helping cancer researchers identify which genetic changes drive tumo...
OBJECTIVES: By comparing deep learning and habitat analysis models based on contrast-enhanced CT (CECT), this study explores a novel approach to predi...
Early stage skin cancer exhibits a high cure rate; however, conventional noninvasive screening suffers from diagnostic inaccuracies, and treatment rel...
Tumor dynamic models are vital for evaluating oncology treatments and guiding clinical drug development decisions. However, few studies rigorously ass...
Despite the initial success of EGFR-targeted therapies in non-small cell lung cancer (NSCLC), the emergence of drug resistance remains a significant c...
OBJECTIVE: To elucidate the anti-rheumatoid arthritis (RA) mechanisms of Notopterygium incisum essential oil (NIEO) using an integrated strategy combi...
The unprecedented success of mRNA vaccines during the COVID-19 pandemic has accelerated the development of nucleic acid-based therapeutics, particular...
BACKGROUND: Improving screening coverage is a central goal of the global strategy to eliminate cervical cancer. In resource-constrained settings, insu...
BACKGROUND: Machine learning (ML) can be used to predict clinical outcomes. Training predictive models typically requires data for hundreds or thousan...
BACKGROUND: Primary cardiac malignancies are rare and highly aggressive, with limited clinical evidence to guide optimal treatment. This study evaluat...
T cell recognition of peptides presented by class I and II human leukocyte antigen (HLA) molecules is fundamental to cancer immunity and personalized ...
BACKGROUND: In clinical stage IA lung adenocarcinoma (LUAD), rapid and accurate intraoperative diagnosis is crucial to decide whether to perform segme...
Post-translational modification (PTM) plays a crucial role in head and neck squamous cell carcinoma (HNSCC) progression, and their specific prognostic...